The presence of genetic influences on cognitive performance and brain volume is well established. However, specific genetic determinants of the variance of these quantitative traits are not yet known. Plexins act as receptors for semaphorins and are implicated in axon guidance, which is a key process in brain development. We have previously shown that plexin B3 is a highly potent stimulator of neurite outgrowth, which makes its gene PLXNB3 an intriguing candidate gene for traits related to human brain development and cerebral connectivity. We identified several polymorphisms in PLXNB3 predicting changes of amino acids (V598I, E1156D and V1596E) conserved at the corresponding positions of the orthologs in mouse and chimpanzee. PLXNB3 was genotyped in 303 healthy volunteers and 42 male patients with schizophrenia. Cognitive performance was measured with the vocabulary test (Wortschatztest (WST)), a method to estimate roughly general intelligence (g). Brain morphology was characterized by magnetic resonance imaging. Compared to subjects not carrying the modern, human-specific haplotype A, carriers of A scored higher in vocabulary test (WST) irrespective of diagnosis (P = 0.0004). This effect could be observed in three independent groups (healthy males: P = 0.048; schizophrenic males: P = 0.034 and healthy females: P = 0.037). Additionally, the haplotype A was associated with increased volume of brain white matter that in turn correlated with performance in the vocabulary test. These findings suggest that plexin B3 may influence cognitive performance, and the development of white matter in vivo in a way similar to its known stimulating effect on neurite outgrowth in vitro. These novel observations warrant further replication in independent samples.
Introduction
The presence of genetic influences on cognitive performance is well established and the various studies converge on heritability estimates between 0.60 and 0.80. 1, 2 Genetic factors also accounted for most of the individual differences in whole brain (90%) and white matter (88%) volume. 3 The correlations between brain volume and cognitive performance are about 0.40 as demonstrated in 14 studies consisting of about 700 individuals. 4, 5 Furthermore, cognitive performance is related to the volume of brain white matter, and this correlation seems to be due to genetic factors. 6 Establishing that the correlation between brain volumes and cognitive abilities is mediated by shared genetic factors is only the first step in unveiling the relation between them. The next step is to identify specific genes that influence both brain volume and cognitive abilities. This approach can also lead to the identification of schizophreniarelated genes because several brain volume and neuropsychological alterations have been described as schizophrenia endophenotypes. The rationale for their use in schizophrenia gene discovery is that these endophenotypes are more elementary compared to clinical phenotypes.
Genes of the plexin family represent intriguing candidates. Plexins act as transmembrane receptors for semaphorins and are implicated in axon guidance, which is a key process in neuronal network formation. 7 We further characterized a member of this family, plexin B3 and demonstrated its predominant neuronal expression in the brain. Expression of plexin B3 in the brain was detected throughout mouse embryonic and postnatal development as well as in the adult human brain. In addition, we showed that plexin B3 is a highly potent stimulator of neurite outgrowth. 8 This prompted us to search for polymorphisms in PLXNB3, the human gene for plexin B3. We identified several single-nucleotide sequence polymorphisms (SNPs). Three of them, coding for V598I (exon 9), E1156D (exon 20) and V1596E (exon 28) result in changes of evolutionarily conserved amino acids of plexin B3. An extended haplotype analysis was subsequently performed in male subjects using several SNPs including the mentioned ones. These polymorphisms cover a genomic interval of 13.271 kb. Genotyping of the SNPs coding for V598I and E1156D allowed the determination of the most common PLXNB3 haplotypes A, B and C. Under the assumption of unique mutation events driving evolution, human haplotype B may have evolved from haplotype C, and 'modern' haplotype A from haplotype B. Based on comparison with published mouse and chimpanzee sequences, haplotype C is assumed to represent the archetypic form. In 27% of the chromosomes analyzed, we found evidence of ancestral recombination events within the 13.27 kb region covered by the SNPs. Therefore, a significant proportion of the haplotypes defined by the SNPs coding for V598I and E1156D do not extend to neighboring genes located B19.5 kb upstream (ABCD1) and B6.4 kb downstream (IDH3G) to PLXNB3. This supports the view that the SNPs coding for V598I and E1156D are well suited for haplotype-based association studies on PLXNB3. We investigated the association between the haplotypes based on the SNPs coding for V598I and E1156D and cognitive abilities in 345 healthy volunteers and male schizophrenic patients. Furthermore, the association with brain morphology was examined in a subset of these individuals.
Materials and methods
Neuropsychological testing and magnetic resonance imaging analysis of human subjects Unrelated healthy Caucasians (115 males, 140 females, mean age 45.4716.0 years, age range 19-79 years), randomly collected from the general population of Munich (Germany), as well as a group of 48 healthy, right-handed male volunteers, matched for age (mean 30.578.9 years) and educational achievement with a group of 42 male right-handed inpatients with schizophrenia (mean age 30.279.0 years), completed the German Wortschatztest 'WST'. 9 WST was constructed from the HAWIE-R (German version of the Wechsler Adult Intelligence Scale, Revised) 10 and is an economical method to estimate roughly general intelligence (g). WST consists of 42 lists each comprising five pseudowords as distractors and one meaningful, real word to be recognized among the distractors. The Spearman-Brown coefficient of the split-half reliability is r = 0.95 and the Cronbach alpha r = 0.94. This test allows to estimate verbal intelligence quotient. The correlation between the WST and the vocabulary subtest of the HAWIE-R 10 is about r = 0.81, and the vocabulary subtest in turn is correlated (r = 0.73) with g. 11 In addition, all subjects of the matched subgroup of 48 unaffected controls and 42 patients with schizophrenia underwent scanning by magnetic resonance imaging (MRI) as described previously. 12, 13 In brief, MRI images were obtained (1.5 T Magnetom Vision, Siemens, Germany) using a coronal T2-and proton density-weighted Dual-Echo-Sequence (repetition time (TR) 3710 ms/ echo time (TE) 22/90 ms; total acquisition time: 9 min; number of acquisitions: 1; field of view (FOV) 230 mm; matrix 256 Â 256; slice thickness 3 mm) and a 3D-MPRAGE sequence (TR/TE 11.6/4.9 ms; total acquisition time: 8 min; number of acquisitions: 1; FOV 230 mm; matrix 512 Â 512; slice thickness 1.5 mm). For further image processing with size reduction from 16 to 8 bit and transformation to a uniform matrix of 256 Â 256 on 192 slices of 1.5 mm slice thickness, the commercial software package ANALYZE was used (Biomedical Imaging Resource, Mayo Foundation, Rochester, MN, USA). All data sets were realigned and resampled three-dimensionally according to the coordinates of Talairach using the program BRAINS (Brain Research: Analysis of Images, Networks and Systems; developed by NC Andreasen and co-workers).
14-17 Segmentation of the MRI data sets in gray and white matter tissue classes and external and internal cerebrospinal fluid (CSF) compartments was performed by using BRAINS. This was performed for the total brain volume and for each cerebral lobe of both sides separately.
Genotyping
Genomic DNA was prepared from 10 ml blood using the QIAamp DNA Blood Maxi Kit (Quiagen, Hilden, Germany) following the supplier's instructions. The SNPs 1906G > A (V598I) and 3582G > C (E1156D) were genotyped by restriction fragment analysis of polymerase chain reaction amplicons of exons 9 (220 bp) and 20 (304 bp), respectively. The change 1906G > A leads to loss of the Tth111I restriction site in exon 9, with G-allelic bands of 161 and 59 bp after cleavage by Tth111I, whereas 3582G > C leads to loss of the EcoR109I site in exon 20, with G-allelic bands of 226 and 78 bp after cleavage by EcoR109I. As PLXNB3 is located on the X-chromosome, haplotypes may be determined unambiguously in male subjects. The haplotypes defined by the two SNPs were defined as following: A, I598-D1156; B, V598-D1156 and C, V598-E1156. Based on mouse and chimpanzee sequences and under maximum parsimonious conditions assumed for the evolution of human haplotypes, haplotype C was assumed to represent the archetypic form and haplotype A to represent the most 'modern' form.
Statistical analysis
Statistics were performed using the Statistical Package for Social Sciences (SPSS) 13.0 Software (SPSS Inc., Chicago, IL, USA, 2004). Socio-demographic covariates of subgroups stratified by genotype were analyzed by t-test or w 2 -test. Non-conditional linear regression analysis was first computed in all men (n = 205) for WST by integrating the factor genotype (haplotype A vs B or C) controlled for diagnosis, age and professional achievement (low, middle, high). The same procedure was then carried out separately for healthy men, schizophrenic men and healthy women. MRI data of the 90 subjects were first analyzed using separate univariate analyses for brain white matter, gray matter and volume of CSF, including diagnosis and genotype controlled for age and intracranial volume. For white matter and CSF volume, we also performed two separate repeated multivariate analysis of covariances (MANCOVAs) assessing the main and interaction effects of the within-subjects factors brain region (frontal, temporal, parietal, occipital) and hemisphere (left, right), and the between-subjects factors diagnosis (patients, controls) and genotype. The covariates age and intracranial volume were added to the analysis. All analyses used two-tailed estimation of significance. The significance level was set at 0.05.
Results
Linear regression analysis entering age, clinical phenotype (schizophrenia vs healthy), professional achievement (low, middle, high) and haplotype (A vs B/C for men and A-carrier vs rest for women) revealed an association of modern haplotype A with higher scores in WST (all men (n = 205): P = 0.0004, r 2 = 0.036; haplotype A (n = 119); mean WST score (s.d.) 33.66 (4.9); haplotype B/C (n = 86) mean WST score (s.d.) 31.38 (8.2)). As shown in Table 1 and Figure 1 , this association was detected in three independent subsamples: schizophrenic men: P = 0.039, r 2 = 0.057; healthy men: P = 0.048, r 2 = 0.016 and healthy women: P = 0.037, .9)). In addition, there was a correlation of the volume of white matter with performance in WST (r = 0.29, P = 0.007; controlled for: age, professional status, diagnosis).
CSF volume was associated with both diagnosis (higher in patients) and genotype (lower in haplotype A-carriers); (repeated measurement MANCOVA F = 5.302, d.f. = 1/85, P = 0.024; haplotype A (n = 58) mean volume (s.d.) 199.7 (34.6); haplotype B/C (n = 33) mean volume (s.d.) 214.5 (50.6)).
Discussion
The main finding of this study is that naturally occurring structural variability of plexin B3, which is involved in axon guidance and neuronal network formation, may be related to normal variance of human-specific cognitive function and brain white matter volume.
Neurological disorders linked to Xq28, the chromosomal band harboring PLXNB3, include a group of diseases caused by mutations in L1CAM, the gene coding for the neuronal cell adhesion molecule L1. This protein has been shown to be involved in axon guidance and fasciculation, and mutations in this gene reduce or abolish L1-dependent neurite outgrowth in vitro. 18 We observed that plexin B3 is an even more potent stimulator of neurite outgrowth when compared to L1. 8 Therefore, PLXNB3 may be considered an interesting candidate gene for the inborn variability in human-specific cognitive functions and brain volume. Several coding and noncoding SNPs allowed an evolutionary analysis of common haplotypes specific for PLXNB3. Two SNPs underlying major haplotypes of PLXNB3 and used for haplotyping in this study lead to human-specific changes of residues otherwise conserved through evolution. In both schizophrenic and mentally healthy males, absence of the most modern and human-specific haplotype A was associated with reduced performance in WST and reduced volume of brain white matter that in turn correlated with reduced performance in WST. As WST gives a rough estimate for g, these data are in line with recent findings of a correlation between white matter and g. The association between PLXNB3 haplotype and white matter volume was independent of the diagnosis and was accompanied by an association of the haplotype with CSF volume in the opposite direction. As CSF volume was also associated with diagnosis and there was no interaction between genotype and diagnosis for CSF volume, we assume a primary influence of PLXNB3 haplotype on white matter volume that in turn indirectly influences CSF volume independently of the previously known association of schizophrenia with CSF volume. 13 Thus, we were unable to find evidence for our hypothesis that genetic variations in plexin B3 might be especially associated with brain volume changes and neuropsychological impairments in schizophrenia, that is that the association is stronger in the patients in comparison to healthy subjects. On the other hand, there is a trend for a genotype effect on gray matter and the interaction of diagnosis by genotype on gray matter is also suggestive though nonsignificant. Thus, it might well be that our study is underpowered to detect a schizophrenia-related effect on gray matter. This important issue should be followed up in replication studies in larger samples.
It is well worthy to emphasize that the variations in PLXNB3 were associated with verbal performance in three independent samples, schizophrenic patients, healthy males and healthy females. Whereas these replications add much credibility to the findings, the associations of the PLXNB3 haplotype with verbal performance and white matter volume were not strong. Although this is not unexpected, as both traits are supposed to be under polygenic influence, these potentially highly important findings warrant further replication before generalization. Furthermore, WST was the only cognitive test available from all cohorts. It remains to be investigated which cognitive dimension correlates most specifically and thus possibly stronger with the PLXNB3 haplotype. It should be emphasized that also these findings warrant further multiple replications in order to avoid spurious associations, which are common to genetic association studies. The mechanisms by which the V598I and/or E1156D missense variations or other linked sequence variants might actually act on cognitive performance and white matter volume can only be speculated about and require further investigation. If the association findings can be confirmed in replication studies, detailed functional analysis of structural variants of plexin B3 may help to identify the polymorphisms most important for the association findings.
To our knowledge, this is the first study that examines the relationship between PLXNB3 haplotypes and human-specific cognitive abilities and white matter volume and one of the first reports on the influence of common genetic variations on both, brain structure and function. The association of human-specific higher cognitive functions like verbal performance and brain white matter volume with human-specific polymorphisms affecting conserved amino acids of a protein with a predominant neuronal expression is intriguing and deserves further investigation.
